donald_johns_biogen_idec

Biogen Idec hires from Novartis to head ALS

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …

Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

Trials image

Publish all clinical trials, say pharma doctors

August 29, 2014
Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency

All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …

Amgen image

Amgen submits next gen cholesterol drug

August 29, 2014
Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins

Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …

marybeth-loesch

MSC hires new president and chief executive

August 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mary Beth Loesch, msc

US healthcare performance firm Medical Simulation Corporation has confirmed the appointment of Mary Beth Loesch as its president and chief executive. Loesch …

GSK image

GSK Ebola vaccine fast-tracked into human trials

August 28, 2014
Sales and Marketing Africa, Ebola, GSK, WHO, zmapp

GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …

david_cameron

Government rips up blank cheque on cancer drugs

August 28, 2014
Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …

xiaohui_zheng

Biostar appoints chief scientist

August 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xiaohui Zheng, biostar pharmaceuticals

Chinese manufacturing and marketing firm Biostar Pharmaceuticals has hired professor Xiaohui Zheng as its chief scientist.Zheng is a professor and director of …

George W Bush

Ice Bucket Challenge nears $100m in donations

August 28, 2014
Medical Communications, Research and Development, Sales and Marketing Clovis Pharma, Motor Neurone Disease Association

Charitable donations to a once obscure healthcare charity called the ALS Association have rocketed in August after its #IceBucketChallenge went …

Biogen Idec logo

NICE final ‘yes’ for Biogen’s MS pill

August 27, 2014
Sales and Marketing Aubagio, Biogen, RMS, RRMS, gilenya

In final guidance published today NICE has recommended NHS funding of Biogen Idec’s new multiple sclerosis pill in patients with …

Merck Serono breaks ground in China with new plant

August 27, 2014
Manufacturing and Production, Sales and Marketing China, Merck Serono, manufacturing, metformin

Merck Serono has broken ground for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be …

Pfizer Xalkori

US rivals Pfizer and Merck team up for lung cancer

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab

The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …

UK nurse with Ebola given new drug in London

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp

A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …

monge_maria

Miriam Monge to join Sartorius Stedim Biotech

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sartorius Stedim Biotech (SSB), a pharma and biotech supplier, today announced the appointment of Miriam Monge as director of marketing …

astrazeneca_sign_sky_14

AstraZeneca and Illumina in new partnership

August 26, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing

AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …

astrazeneca_double_logo

AZ launches US digital tool ‘DoctorsNotes’ in US

August 26, 2014
Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital

AstraZeneca has launched a new online tool in the US called DoctorsNotes to help medical professionals keep better up to …

Merck logo

Merck and Advaxis team up on immuno-oncology

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

nricciardi_asterias

Asterias Biotherapeutics adds two to board

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer

US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …

NICE and market access: time for reform?

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

The Gateway to Local Adoption Series

Latest content